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Objective: Our objective was to assess survival, need for pacemaker inser- 
tion, and rejection frequency with a new surgical technique of orthotopic 
heart transplantation using bicaval and pulmonary venous anastomoses. 
Methods: We retrospectively reviewed 100 consecutive patients who had 
orthotopic heart transplantation with this technique between July 1991 and 
September 1995. Results: The mean age was 57.0 - 11.1 years, with 51 
patients being 60 years or older. The mean donor/recipient weight ratio was 
0.92, and in 28 patients the ratio was less than 0.8. The early (30-day) 
survival was 100% and the 1- and 2-year survivals were 98% -+ 2% and 96% 
--- 2%, respectively. Survival was not affected by age or by the duration of the 
OKT3 therapy (p > 0.2 for each of these parameters). The seven late deaths 
were due to infection (n = 2), graft atherosclerosis (n = 3), acute rejection 
(n = 1), and nonspecific graft failure (n = 1). No permanent pacemaker 
was required in the first 6 months after the operation, and all the patients 
were discharged in normal sinus rhythm. Freedom from treated r jection 
was significantly greater in patients with 7 days of OKT3 therapy than in 
patients with 14 days of therapy (p < 0.0001). Conclusions: Orthotopic heart 
transplantation with bicaval and pulmonary venous anastomoses offers an 
improved alternative to the standard biatrial technique, with a 30-day mortal- 
ity of 0% in 100 consecutive patients, excellent intermediate-term survival, and 
elimination of the need for pacemaker insertion. More normal anatomic 
configuration and synchronous function of the atria may have contributed to 
these results. (J Thorac Cardiovasc Surg 1996;112:1496-503) 
T hirty years ago, Shumway, Lower, and Stofer 1 originally described what has become the stan- 
dard technique for orthotopic heart transplantation. 
An observation was subsequently made that the 
anastomosis of donor and recipient atria creates 
enlarged atria with an abnormal geometric onfigu- 
ration and associated mitral and tricuspid regurgi- 
tation.2, 3Recently, an alternative technique of "to- 
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tal" orthotopic heart transplantation was described, 
the essential features of which are complete xcision 
of the recipient atria and donor heart implantation 
with bicaval end-to-end anastomoses and pulmonary 
venous anastomoses. 4-6This latter technique pro- 
duces a nearly normal anatomic onfiguration of the 
atria and as a consequence offers the potential for 
more synchronous atrial contraction, elimination of 
the need for pacemaker implantation, and reduced 
atrioventricular valve regurgitation. 
We report herein our clinical experience with 100 
consecutive patients who underwent heart trans- 
plantation for which bicaval and pulmonary venous 
anastomoses were used. 
Patients and methods 
Patients. From December 1988 to October 1995, 171 
patients underwent orthotopic heart transplantation at
our institution. We retrospectively evaluated the 100 
consecutive patients in whom the bicaval and pulmonary 
venous anastomotic technique was used between July 
1991 and October 1995. We excluded seven patients in 
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whom a modified technique, consisting of bicaval anasto- 
moses for the right atrium and standard atrial anastomosis 
for the left atrium, 7was used. 
Surgical technique for donor heart harvesting. The 
donor's heart is harvested in the usual fashion with some 
technical modifications. The superior vena cava (SVC) is 
transected at or above the azygos vein. The inferior vena 
cava (IVC) is divided at the diaphragmatic reflection. The 
pulmonary veins are divided at their entrance into the 
pericardium, and then the cuffs of the superior and 
inferior pulmonary veins are joined by an incision to 
create a single left and single right orifice, leaving a bridge 
of intact posterior left atrial wall between them. 
Surgical technique for recipient. Arterial cannulation 
is done in the standard fashion. For venous cannulation, 
the SVC is dissected free circumferentially, with the 
pericardial reflection being divided; the cannula is placed 
high on the vessel. The IVC is dissected free from the 
diaphragmatic reflection and cannulated low, as the IVC 
emerges from the diaphragm. The recipient heart is then 
explanted by transecting the SVC at the cavoatrial junc- 
tion, and the IVC is divided with a generous cuff of right 
atrium. The left atrium is removed completely, leaving 
only two left atrial cuffs that include the ostia of the 
pulmonary veins on either side. The implantation of the 
donor's heart begins with the anastomosis of the left atrial 
cuff containing the left pulmonary veins to the corre- 
sponding orifice in  the donor's left atrium. The right 
pulmonary veins are anastomosed in the same fashion. 
When both lungs are harvested, there may not be suffi- 
cient left atrial cuff for the cardiac allograft, in which case 
a modified technique can be used as described elsewhere. 7 
The SVC and the IVC are then anastomosed in an 
end-to-end fashion. Frequently, however, the donor heart 
IVC has been transected close to or at the right atrium, to 
provide sufficient length for a liver allograft. In these 
circumstances, a generous cuff of right atrium around the 
recipient IVC will facilitate the end-to-end anastomosis. 
The aorta and pulmonary artery are reconstructed in the 
usual manner. 
Immunosuppressive prophylaxis. All patients received 
an induction course of murine monoclonal antibody mu- 
romonab-CD3 (5 mg intravenously daily) (Orthoclone- 
OKT3; Ortho Biotech, Raritan, N.J.). The duration of this 
induction therapy changed from 14 to 10 days in Novem- 
ber 1992 and has been 7 days since September 1993. All 
patients received an immunosuppressive regimen consist- 
ing of azathioprine 4 mg/kg intravenously before the 
operation and 2 mg/kg daily after the operation; methyl- 
prednisolone 500 mg intravenously at the time of cross- 
clamp removal and 125 mg every 8 hours for three doses 
followed by oral prednisone 0.25 mg/kg daily during 
induction therapy, and thereafter 0.50 mg/kg. Oral cyclo- 
sporine 5 mg/kg twice daily was started within 48 to 72 
hours after the operation, after renal function had stabi- 
lized. Prednisone was tapered over a period of 6 months 
to 1 year, according to the results of endomyocardial 
biopsies. 
Postoperative follow-up. Endomyocardial biopsy, right 
heart catheterization, and thermodilution cardiac output 
were obtained at specified intervals after the operationP 
Mitral and tricuspid regurgitation were determined by 
means of Doppler echocardiography. Hemodynamic and 
echocardiographic data were excluded if patients had 
acute cellular rejection (grade ->IB according to the 
criteria of the International Society for Heart and Lung 
Transplantation 9) or humoral rejectionJ °' 11 
Statistical analysis. Freedom from an event (death or 
rejection) was analyzed by means of life table methods 
and actuarial curves were compared by means of the 
log-rank test. A Cox stepwise regression was used in 
multivariate analyses. For each patient, cardiac output 
and cardiac index values closest o 2 weeks, 6 months, and 
1 year after the operation were selected and were com- 
pared by means of an analysis of variance. 
Data are summarized as mean -+ standard eviation for 
continuous variables and as frequencies and percents for 
categorical values. All testing was two-sided using an c~ 
level of 0.05, without adjustment for multiple testing. 
Results 
Preoperative recipient and donor characteristics. 
The mean age of the patients was 57.0 _ 11.1 years 
and the range from 14 to 77 years. Fifty-one patients 
were more than 60 years old (mean age of 65.4 years 
for this group). The majority of the patients were 
male (92%) and white (82%), 11% were black, 3% 
Hispanic, and 4% Asian. The diagnoses were almost 
equally distributed between ischemic (52%) and 
idiopathic cardiomyopathy (44%). Four patients 
had other diagnoses: sarcoidosis (n = 1), doxorubi- 
cin (Adriamycin) toxicity (n = 1), congenital heart 
disease (n = 1), and amyloidosis (n = 1). The mean 
left ventricular ejection fraction was 19.5% and the 
average pulmonary artery systolic pressure was 
51.7 + 19.2 mm Hg. No patient was declined 
because of pulmonary hypertension, but patients with 
elevated pulmonary vascular resistance were treated 
with vasodilators, including intravenous nitroglycerin, 
nitroprusside, or prostaglandin E 1 during the operative 
procedure and the perioperative period. 
Donors were matched on the basis of blood type 
and body weight. The mean donor/recipient weight 
ratio was 0.92. A weight mismatch of more  than 20% 
(donor/recipient weight ratio <0.8) occurred in 28 
patients (28%). 
Early (30-day) survival was 100% (Fig. 1). One- and 
2-year survivals were 98% _+ 2% and 96% _+ 2%, 
respectively. Recipient age and donor/recipient weight 
mismatch did not affect survival (p > 0.2 for each of 
these parameters). The same applies to the duration of 
OKT3 therapy. The survival curves of patients with the 
three durations of OKT3 therapy are shown in Fig. 2. 
The seven late deaths were due to infections (n = 2), 
graft atherosclerosis (n = 3), acute rejection (n = 1), 
and nonspecific graft failure (n = 1). 
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Fig. 1. Actuarial survival after orthotopic heart transplantation using bicaval nd pulmonary venous 
anastomoses. Survival is shown for all patients and is also stratified according to the age of the recipient. 
Older (->60 years) and younger (<60 years) patients did not differ significantly in survival. All mortalities 
were included in the analysis. The box inset indicates the probabilities of survival at 30 days, 1 year, and 2 
years. Numbers below the figure indicate patients at risk during follow-up, ns, Not significant; SE, standard 
error. 
Postoperative cardiac output. Cardiac output 
and cardiac index were analyzed at 2 weeks, 6 
months, and 1 year after transplantation. When 
patients with differing durations of OKT3 therapy 
were stratified and compared (data not shown), 
patients with a longer duration of OKT3 therapy 
demonstrated increased values for cardiac output 
and cardiac index at 2 weeks (p < 0.001), but not at 
later evaluations. 
Postoperative Doppler echocardiography. One 
year after transplantation, 50 patients had Doppler 
echocardiographic evaluation. Of these, 11 (22%) 
had a degree of mitral regurgitation of2+ or greater 
(10 had 2+ and one patient had 3+; scale 0 to 4+). 
Similarly, 18 (36%) had 2+ or more tricuspid regur- 
gitation (16 patients had 2+ and two patients had 
3+; scale 0 to 4+). 
Treated rejection. Actuarial analysis of freedom 
from treated rejection is shown in Fig. 3, stratified 
according to the duration of OKT3 therapy. It is 
clear that treated rejection is less common inpa-  
tients with only 7 days of therapy than i patients 
with 14 days of therapy (p < 0.0001). 
Similarly, the duration of OKT3 therapy was 
strongly related to the number of episodes of rejec- 
tion in the first year after transplantation. Patients 
with 7 days of OKT3 therapy had a mean of 0.4 
rejections in the first year, compared with 1.1 for 
patients with 14 days of OKT3 therapy (p = 0.0002). 
Pacemaker placement. Insertion of a pacemaker 
was not required in any patient within the first 6 
months after transplantation, a d all the patients 
were discharged in normal sinus rhythm. One pa- 
tient required permanent pacemaker implantation 7 
months after the operation for high-grade atrioven- 
tricular block. 
Discussion 
The concept of "total" orthotopic heart ransplan- 
tation with bicaval and pulmonary venous anasto- 
moses was first introduced by Dreyfus, 4 Yacoub, 12 
and their associates. The surgical technique used in 
our center differs from that used by other groups in 
two important aspects: first, a portion of azygos vein 
is incorporated into the SVC anastomosis, which 
may reduce the occurrence of anastomotic stenosis 
(none since this modification has been used); sec- 
ond, two small buttons of atrial tissue are excised 
with the left and right pulmonary veins, instead of 
one large atrial button, thus allowing more donor 
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Fig. 2. Actuarial survival after orthotopic heart transplantation, stratified by duration of OKT3 induction 
therapy. There was no significant difference in survival among patients treated with the three durations of 
OKT3 therapy. All mortalities were included in the analysis, ns, Not significant; SE, standard error. 
left atrial tissue to be transplanted, possibly resulting 
in better left atrial function. 
We became interested in this technique because 
we noted a high incidence of permanent pacemaker 
requirement in the early postoperative period 13 
(14% or nine of 64 patients) with the standard 
technique. Our initial intent o perform a random- 
ized prospective trial comparing the traditional sur- 
gical technique with the new one was abandoned 
because of the uniform lack of need for permanent 
pacemaker insertion oted in the first 10 patients in 
whom the bicaval technique was used. For this 
reason, the decision was made to continue using the 
new technique so long as the patient was in normal 
sinus rhythm. This continues to be true for 124 
consecutive patients, none of whom required a 
permanent pacemaker in the first 6 months after the 
operation and all of whom were discharged in 
normal sinus rhythm. This clear electrophysiologic 
advantage has been confirmed by other randomized 
and prospective trials. E1 Gamel and coworkers 14 
randomized 40 patients to the bicaval technique and 
35 patients to the standard technique. A permanent 
pacemaker was required in three patients with the 
standard technique versus none with the bicaval 
technique. They also noticed that the patients in 
whom the bicaval technique was used had signifi- 
cantly fewer tachyarrhythmias (2/40 versus 11/35 
with standard technique). A similar incidence of 
atrial arrhythmias was found by Deleuze and col- 
leagues 15 in a randomized study. Retrospective stud- 
ies by Brandt, Harringer, and Hirt 16 and by 
Jeevanandam and coworkers 17 have demonstrated a 
decreased incidence of atrial flutter and fibrillation 
and sinus node dysfunction and improved survival in 
patients in whom the bicaval technique was used. 
From an electrophysiologic standpoint, we can 
conclude that sinus node dysfunction and atrial 
bradyarrhythmias necessitating pacemaker inser- 
tion, which were recognized early in the transplant 
experience~S, 19 and attributed to the atrial incision, 
surgical trauma to the sinus node, and surgical 
distortion of the atrium after implantation, have 
been almost completely eliminated by the bicaval 
technique. 
Atrioventricular valve function in the posttrans- 
plantation period has been studied by Doppler 
echocardiography in several reports. A surprisingly 
high incidence of mitral regurgitation (13/20 pa- 
tients, 60%) and tricuspid insutficiency (17/20 pa- 
tients, 85%) was observed by Angermann and asso- 
ciates z in patients in whom the standard technique 
was used. Stevenson and coworkers 3 confirmed 
these findings. The current study reveals that at 1 
year, the incidence of tricuspid and mitral regurgi- 
tation was substantially lower in our patients when 
1500 Trento et al. 
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Fig. 3. Actuarial freedom from treated rejection according to duration of OKT3 therapy. There was 
significantly greater f eedom from treated rejection i  patients treated with 7 days of OKT3, in comparison 
with 14- and 10-day courses. For the entire population, freedom from treated rejection was 64% _+ 5% at 
30 days, 51% -+ 5% at 1 year, and 49% -+ 5% at 2 and 3 years. SE, Standard error. 
compared with the literature reports. This improve- 
ment in atrioventricular valve function in patients in 
whom the bicaval technique was used has been 
documented by other authors,  who found less 
tricuspid regurgitation or less mitral regurgitation 
(or both) when these patients were compared with 
those in whom the standard technique was used. In 
one series by Leyh and associates, 2° this difference 
became apparent only during exercise. 
Atrial function after transplantation has also been 
the object of clinical and experimental investigation. 
In our institution, 21left atrial transport and function 
were evaluated by means of Doppler echocardiog- 
raphy in transplant recipients and normal control 
subjects. We found that left atrial transport and 
ejection force were similar in normal control sub- 
jects and patients undergoing the new transplanta- 
tion technique, but were significantly lower in the 
standard technique group. In another study using 
magnetic resonance imaging, 22 we found that the 
right and left atrial emptying fractions, as defined by 
the difference between atrial diastolic and systolic 
volumes divided by atrial diastolic volume, were 
significantly higher in the new technique group than 
in the standard technique group. Thus the bicaval 
and pulmonary venous anastomotic technique pro- 
duces more physiologic atrial function than the 
biatrial technique, as evidenced by greater atrial 
ejection force and more normal atrial transport and 
atrial emptying fractions. 
In an animal model, Goldstein and associates 23 
have shown that synchronous atrial contractility 
constitutes an important compensatory response to 
right ventricular dysfunction. This finding was con- 
firmed in patients with right ventricular infarction 
who manifested severely compromised cardiac func- 
tion with right ventricular asynchrony or depressed 
A waves (an indication of right atrial dysfunction). 
Recent experimental work from Bittner, Chen, and 
Kendall 24 compares the two surgical techniques, 
with respect to atrial function, atrioventricular con- 
duction, biventricular filling, and compliance in a 
dog model, using functional analysis, micromanom- 
etry, sonomicrometry, and ultrasonography. They 
conclude that atrial systole and right and left ven- 
tricular diastolic filling are better preserved with 
total orthotopic heart ransplantation than with the 
standard technique. 
The role of an intact right atrium in preventing 
the development of right ventricular failure after 
orthotopic heart transplantation, particularly in pa- 
tients with marginally elevated pulmonary vascular 
resistance, is unknown. However, preliminary data 
from our institution 25show lower mean right atrial 
and pulmonary arterial pressures and improved 
cardiac output after transplantation performed by 
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the bicaval technique (in comparison with the tradi- 
tional technique) in patients with high preoperative 
pulmonary vascular resistance, indicating a lower 
risk of postoperative right ventricular failure with 
the bicaval technique. 
During the course of the study, there was a 
change in our immunosuppression protocol. The 
duration of OKT3 therapy, in fact, was shortened 
from 14 to 7 days. To evaluate the impact of OKT3 
duration on survival, the patients in whom the 
bicaval technique was used were grouped by dura- 
tion of OKT3 therapy, and survival in the groups 
was compared by the log-rank test. Survival was not 
affected by the duration of OKT3 therapy, but the 
incidence of rejection was. As has been previously 
reported by us and by others, the patients with a 
7-day course of induction therapy have an overall 
lower incidence of rejection because of a signifi- 
cantly lower incidence of humoral rejection, the 
incidence of cellular rejection being the same. Be- 
cause the length of OKT3 therapy was also related 
to posttransplantation cardiac output, cardiac index, 
and mitral and tricuspid regurgitation, analysis of 
these latter outcomes was restricted to patients with 
14 days of OKT3 induction therapy. 
From our experience and from these studies, we 
can conclude that the bicaval and pulmonary venous 
anastomotic technique of total orthotopic heart 
transplantation, by preserving a more normal ana- 
tomic and geometric atrial configuration, has a clear 
electrophysiologic advantage, which is the elimina- 
tion of the need for a permanent pacemaker. There 
is also a very low incidence of atrioventricular valve 
regurgitation. Clinical and experimental studies in- 
dicate that atrial function is improved with the 
bicaval technique and approaches that of a normal 
heart. The improved function conferred by the 
bicaval technique may be especially important in 
patients with high preoperative pulmonary vascular 
resistance and may lower the risk of postoperative 
right ventricular failure. 
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Discussion 
Dr. Bartley P. Gritfith (Pittsburgh, Pa.). I would like to 
comment on the evolution of this surgical technique, then 
to comment on the results of Dr. Trento's series, and 
finally to ask Dr. Trento three questions. 
The technique of orthotopic cardiac transplantation 
began in the laboratories at Stanford and sprang into 
clinical acceptance through that group's work. Lower and 
Shumway have often been quoted for the technique, and 
it has withstood the test of time, with many patients 
benefiting. I suspect that the technique began to give way 
to a bicaval operation as opposed to a right atrial cuff 
technique when the domino procedure was introduced 
into cardiac transplantation. The potential benefits of the 
domino technique with bicaval anastomosis for the recip- 
ients were translated by the apparent reduction in atrial 
arrhythmia, nd perhaps reduction in mitral regurgitation, 
as potentially a preferred method. 
A number of groups subsequently studied bicaval anas- 
tomosis and incorporated the technique that Dr. Trento 
has just described--individual pu monary vein anastomo- 
sis to the left atrium. Most notably, Mr. Yacoub and Dr. 
Dreyfus from Europe reported a series demonstrating 
this. Their results showed an increase in early cardiac 
output but most notably a small decrease in tricuspid 
regurgitation and a significant decrease in tricuspid regur- 
gitation. 
In the last few years Dr. Philippe DeLuz has also 
published a randomized study that includes an exercise 
component, bestowing the virtue of bicaval anastomosis 
and a small left atrial remnant. On the basis of that 
background, it would appear that Dr. Trento's group was 
well advised to enter into this trial. 
I am struck by the stunning skill that Dr. Trento's group 
has demonstrated, not only with the technical aspects of 
this particular procedure, but also with the 100% in- 
hospital survival. They demonstrate significant skill in 
their ability to select patients and care for them. I am 
going to disregard their references to the standard proce- 
dure, because these are noncontemporary control patients 
and probably represent a slightly different ime era. 
I have three questions for you, Dr. Trento. First, can 
you describe the proper performance of the SVC anasto- 
mosis? For instance, do you evert it? Have you seen any 
constrictions, and what do you about hem? Have you had 
trouble fitting laterally displaced pulmonary veins re- 
moved from those patients who have a large left atrium 
back into the small donor heart that is to be placed? 
Second, is the early hemodynamic benefit that you pro- 
pose the result of the preservation of sinus rhythm? If so, 
why is this benefit evanescent? Third, what is your expla- 
nation for the apparent reduction in mitral regurgitation 
with the total orthotopic transplant versus other less 
radical left atrial procedures? You have demonstrated 
that only 11 of 50 patients (22%) have mitral regurgita- 
tion, and this is the lowest number that I have seen 
published. Do you think this is solely because of the 
independent pulmonary venous anastomosis and more 
complete preservation of left atrial anatomy? 
Dr. Trento. Thank you for your comments, Dr. Griffith. 
Early in our experience we did have one SVC stenosis. 
To avoid this complication, we transect the recipient SVC 
with 1 mm or 2 mm of right atrial cuff. We have used this 
technique in about 90 patients without any problem. We 
also used an azygos vein to enlarge the donor SVC stump. 
Regarding the surgical technique for the SVC anastomo- 
sis, we have tried the everting suture technique a few 
times, but we went back to the usual inverting, sewing 
from the inside technique, by using a very fine suture of 5 
or 6-0 polypropylene and taking very small bites of tissue. 
To answer your last question, regarding technical prob- 
lems due to size discrepancy of the donor and the 
recipient's heart: If the IVC of the donor's heart is far 
away from the recipient's IVC stump, we align the right 
pulmonary veins, keeping in mind the IVC position. If we 
detect tension while we perform the IVC anastomosis, 
once the snaring tapes are released, the tension is com- 
pletely released. 
We do think that there is an early hemodynamic 
advantage with the new technique connected with the 
normal sinus rhythm in the patient. We have retrospec- 
tively examined our patients on the basis of their pulmo- 
nary vascular esistances, and we have seen that patients 
with high pulmonary vascular esistances have a lower 
right atrial pressure and pulmonary artery pressure with 
the bicaval technique than do the patients with the biatrial 
technique. Obviously these are retrospective r views and 
their meaning is questionable. 
Regarding the cause of mitral regurgitation, I think that 
by performing the individual pulmonary venous anasto- 
mosis you do obtain a normal-size l ft atrium. If you leave 
a posterior atrial cuff joining the two pulmonary veins, you 
will have a more enlarged left atrium with possibly abnor- 
mal atrial geometry. That is the only explanation that I can 
offer for the lower incidence of mitral regurgitation. 
Dr. Gilles D. Dreyfus (Paris, France). I would like to 
congratulate Dr. Trento for these superb results, which we 
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were unable to achieve. After Sir Magdi Yacoub, we had 
proposed in 1991 this modified orthotopic transplant 
technique after a presentation by Angermann showing 
many morphologic and physiologic imperfections of the 
standard technique at transesophageal chocardiography. 
Since then we have performed more than 50 of those 
transplantations, but we were unable to prove any hemo- 
dynamic superiority at the early phase when comparing 
the two techniques. What we have seen is that we could 
avoid thrombus formation, which can occur with the 
standard technique and may lead to strokes. 
Unlike you, we have had one pacemaker implantation 
after the modified technique but have a significant de- 
crease in the incidence of arrhythmias. I therefore have 
three questions. How do you explain that you did not 
require pacemaker implantation with the modified tech- 
nique? Would you agree that many of the atrioventricular 
blocks that are encountered after orthotopic transplanta- 
tion may be related to the preservation technique more 
than to the surgical technique? Do you believe that 
hemodynamic superiority of the complete technique as 
opposed to the standard technique, which could not be 
demonstrated at rest, probably could be demonstrated 
with exercise. Are you intending to try to prove that? 
Finally, you have clearly shown a reduced incidence of 
both mitral and tricuspid regurgitation. We have found 
the same result. However, this fate is denied by those 
who favor the bicaval technique as opposed to the 
standard technique. Could you explain the difference 
between those two techniques with regard to mitral 
regurgitation? 
Dr. Trento. To answer your last question, the bicaval 
and pulmonary vein anastomosis technique leaves a nor- 
mal left atrial anatomy. I think the absence of a pace- 
maker requirement in our experience is due to the fact 
that we do not touch any of the conduction tissue in the 
atrium. Our preservation technique is the same that was 
used 15 years ago--the Stanford solution--so I do not 
think it is a question of preservation. Yes, we are in the 
process of doing exercise testing to determine whether the 
hemodynamic advantage of the new technique is more 
evident during exercise. 
